Skip to main content
. 2022 Jul 13;33(13-14):740–756. doi: 10.1089/hum.2021.255

Table 1.

Dosages and dose regimen of anti-inflammatory and immunosuppressive agents used in the 13-week mechanistic study

Group Name Concentration Dose Dose Volume Route Dosing Days
3 Prednisolone (10 mg as tablets)a 1 mg/mL 1 mg/kg/day 1 mL/kg Oral (gavage) Day −1 to 29, and then day 31, 33, 35, 37, 39, and 41
4 Rituximabb 10 mg/mL 20 mg/kg 2 mL/kg Intravenous Every 2 weeks (day −14, day −1, 14, 28, 42, 56, 70, and 84)
4 Everolimus (2.5 mg as tablets)a 0.5 mg/mL 0.5 mg/kg/day 1 mL/kg Oral (gavage) Daily, week −2 until end of the dosing phase (day 14)
a

As these are tablets, they were dissolved in normal drinking water and administered orally by gavage after a visual check for correct dissolution.

b

Diphenhydramine is an antihistamine, which has been administered intramuscularly as a premedication 30–60 min before rituximab administration at a concentration of 50 mg/mL, a dose of 4 mg/kg, and a volume of 0.08 mL/kg.